Overstating the evidence – double counting in meta-analysis and related problems

Overview of attention for article published in BMC Medical Research Methodology, February 2009

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
Among the highest-scoring outputs from this source (#30 of 2,064)
High Attention Score compared to outputs of the same age (99th percentile)
High Attention Score compared to outputs of the same age and source (99th percentile)

Mentioned by

blogs: 2 blogs
policy: 1 policy source
twitter: 138 tweeters

facebook: 1 Facebook page
wikipedia: 1 Wikipedia page

Citations

dimensions_citation: 123 Dimensions

Readers on

mendeley: 110 Mendeley
citeulike: 2 CiteULike

Summary Blogs Policy documents Twitter Facebook Wikipedia Dimensions citations

So far, Altmetric has seen 1 policy document that references this research output.

Brigatinib for treating ALK-positive advanced non-small-cell lung cancer after crizotinib : Appraisal consultation committee papers

Cited by National Institute for Health and Care Excellence on 26 Sep 2018

The National Institute for Health and Care Excellence (NICE) in the UK provides national guidance and advice to improve health and social care.

This page shows the most recent policy documents that mention this research output.

Click here to find out how to access more activity.